By proceeding, you agree to our Terms of Use and Privacy Policy.
Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health.
25-27 January 2022
Welcome to the 6th Microbiome Movement - Drug Development Summit Europe As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel
Event Ended
Virtual
Paid
29-30 March 2022
Dedicated to exploring microbiome research and strategies for commercialisation and product development, we bring together KOLs to present a series of R&D case studies. Topics covered include gut health and disease, advances beyond the gut including
USA
San Diego
Global Engage is pleased to announce the 9th Microbiome & Probiotics R&D and Business Collaboration Forum, which is confirmed to take place on March 29-30 2022 at the Sheraton San Diego Hotel and Marina.
21-23 June 2022
The 7th Microbiome Movement - Drug Development Summit?returns to Boston at a pivotal time. As the microbiome therapeutic space matures, with more indications being pursued and more companies conducting trials, the focus of this event - now in its 7th
Boston
16-17 November 2022
The 7th Annual Microbiome Connect: USA 2022 is dedicated to showcasing the leading drug development platforms applying microbes, microbe modulators and microbial-derived components to prevent or treat human diseases or make medical diagnosis.
31-02 February 2023
From hypothetical to reality, the first ever approval of a microbiome-based therapy is here and is set to propel the industry forward, expanding across a wide range of diseases.
UK
London
19-20 October 2023
The 2023 Microbiome & Probiotics R&D and Business Collaboration Forum comes at an exciting time for the microbiome industry. The recent FDA approvals for Seres Therapeutics and MaaT Pharma (Phase III Clinical Trial), along with Vedanta Biosciences’ s
It is an exciting time for the microbiome industry and recent FDA approvals and successful fundraising point towards the industry’s potential for therapeutic applications. Developments in the Skin space such as partnerships, collaboration, and licens